Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cavalier, S. J.
Right arrow Articles by Gambetti, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cavalier, S. J.
Right arrow Articles by Gambetti, P.
NEUROLOGY 1981;31:714
© 1981 American Academy of Neurology

Dystrophic axons and spinal cord demyelination in cystic fibrosis

Steven J. Cavalier, M.D. and Pierluigi Gambetti, M.D.

From the Division of Neuropathology. Institute of Pathology, Case Western Reserve University, and the Department of Neurology, Cleveland Clinic Foundation, Cleveland, OH.

Neuropathologic changes in patients with cystic fibrosis include dystrophic axons in the nucleus gracilis and demyelination of the fasciculus gracilis. We reviewed 43 autopsy cases of cystic fibrosis to determine the incidence and severity of these changes. Sixty-six percent of patients developed dystrophic axons. There was a direct correlation between severity of neuroaxonal dystrophy and duration of disease. Demyelination of the fasciculus gracilis occurred in 11%. The neuropathology of cystic fibrosis resembles that of vitamin E deficiency in animals. However, vitamin E replacement failed to prevent neuropathologic changes in these patients.

Address correspondence and reprint requests to Dr. Cavalier, Cleveland Clinic Foundation, 9500 Euclid Avenue, Box 402, Cleveland, OH 44106.

Supported in part by NIH Grant No. NS14509.

Accepted for publication September 3, 1980.




This article has been cited by other articles:


Home page
PediatricsHome page
R. L. Koscik, P. M. Farrell, M. R. Kosorok, K. M. Zaremba, A. Laxova, H.-C. Lai, J. A. Douglas, M. J. Rock, and M. L. Splaingard
Cognitive Function of Children With Cystic Fibrosis: Deleterious Effect of Early Malnutrition
Pediatrics, June 1, 2004; 113(6): 1549 - 1558.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by AAN Enterprises, Inc.